Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast

International Journal of Cancer

Volumn 96, Issue SUPPL., 2001, Pages 97-104

  Neuschatz, Andrew C ^a   DiPetrillo, Thomas ^a,b   Safaii, Homa ^a   Lowther, David ^a   Landa, Marcia ^a   Wazer, David E ^a,b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Ductal carcinoma in situ (DCIS); Radiation therapy; Wide excision

Indexed keywords

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CARCINOMA IN SITU; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE;

ADULT; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MIDDLE AGED; NECROSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035738698     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10357     Document Type: Article

References (27)

1. A prognostic index for ductal carcinoma in situ of the breast
2. The influence of margin width on local control of ductal carcinoma in situ of the breast
3. Mammary ductal carcinoma in situ with microinvasion
4. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed
5. Planning of Ir-192 seed implants for boost irradiation to the breast
6. Nonparametric estimation from incomplete observations
7. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
8. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from national surgical adjuvant breast and bowel project B-17
9. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomized phase III trial 10853
10. Radiotherapy and tamoxifen following complete local excision in the management of ductal carcinoma in situ: Preliminary results from the UK DCIS trial
11. Tamoxifen in treatment of intraductal breast cancer: National surgical adjuvant breast and bowel project B-24 randomised controlled trial
12. Pathologic findings from NSABP protocol B-17
13. Pathologic findings from NSABP eight-year update of protocol B-17
14. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ: Analysis of EORTC trial 10853
15. Outcomes and factors impacting local recurrence of ductal carcinoma in situ
16. Ductal carcinoma in situ detected in the mammographic era: An analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy
17. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ
18. Long term follow-up of women with ductal carcinoma in situ treated with breast conserving surgery
19. Impact of young age on outcome in patients with ductal carcinoma in situ treated with breast conserving therapy
20. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy
21. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999
22. Developing a prognostic index for ductal carcinoma in situ of the breast
23. Understanding ductal carcinoma in situ
24. Treatment selection in ductal carcinoma in situ
25. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden
26. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast